Evidence map›Paper›PMID 39526145›Full record

ArticleJournal of medical physics

Composite Iodine-gold Nanoparticles as a Contrast Agent in Computed Tomography.

Rezvan Ravanfar Haghighi, Fariba Zarei, Samira Moshiri, Anahita Jafari, Sabyasachi Chatterjee, Vyas Akondi, Vani Vardhan Chatterjee

Abstract read
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rezvan Ravanfar HaghighiMedical Imaging Research Center, Shiraz, Iran.
Fariba ZareiMedical Imaging Research Center, Shiraz, Iran.
Samira MoshiriMedical Imaging Research Center, Shiraz, Iran.
Anahita JafariMedical Imaging Research Center, Shiraz, Iran.
Sabyasachi ChatterjeeRetired Scientist from Indian Institute of Astrophysics; Ongil, 79 D3, Sivaya Nagar Reddiyur, Alagapuram, Tamil Nadu, India.
Vyas AkondiDepartment of Physical Sciences, Indian Institute of Science Education and Research, Government ITI Building, Berhampur, Odisha, India.
Vani Vardhan ChatterjeeDepartment of Applied Physics and Instrumentation, Indian Institute of Science, Bengaluru, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Solutions of iodine-based compounds, due to their high X-ray attenuation coefficient, are widely used as contrast agents in computed tomography (CT) imaging. This paper investigates the attenuation properties of iodine and gold to develop nanoparticle-based contrast agents, for example, composite nanoparticles (NPs) with layers of iodine and gold or a mixture of NPs of gold and iodine. Materials and Methods: A theoretical formula is derived that gives the Hounsfield Unit (HU) for different weight-by-weight (w/w) concentrations of a mixture of blood + iodine + gold. The range of compositions for which iodine + gold mixture can give a suitable HU ≥ Results: It is seen that for an aqueous solution of iodine, the suitable HU of 250 (hence giving sufficient gray level to the CT image) can be obtained with w/w concentrations of iodine being 0.0044, 0.008, and 0.0097 for observations at 80, 100, and 120 kVp, respectively. The corresponding w/w concentrations of gold NPs would be 0.0103, 0.0131, and 0.0158. With these basic results, compositions of suitable mixtures of iodine and gold are also specified. Conclusion: Aqueous suspensions of gold NPs are suitable as contrast materials for CT imaging and can also be used as a component of a composite contrast material consisting of an iodine and gold mixture.

Indexed as

Computed tomographycontrast agentnanoparticles

Identifiers

PMID39526145
PMCPMC11548064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.